MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Longitudinal clinical and biomarkers characteristics of non-manifest LRRK2 G2019S carriers: The PPMI cohort

    T. Simuni, K. Merchant, M. Brumm, C. Caspell-Garcia, H. Cho, C. Coffey, L. Chahine, A. Siderowf, C. Tanner, K. Marek, P. Investigators (Chicago, USA)

    Objective: To examine 2-year longitudinal change in clinical, dopamine transporter (DAT) imaging and biofluid biomarkers in non-manifesting carriers (NMCs) of LRRK2 G2019S versus healthy controls…
  • 2022 International Congress

    Longitudinal study of Parkinson’s disease-related pattern with resting state functional MRI

    A. Vo, N. Nguyen, D. Eidelberg (Manhasset, USA)

    Objective: To validate the previously characterized resting-state fMRI (rs-fMRI) Parkinson’s disease (PD)-related pattern, termed fPDRP, in a large multi-site PD imaging database, and to assess…
  • 2022 International Congress

    P2B001 in the management of untreated PD. Results from a randomized, double-blind, double-dummy controlled trial

    C. Olanow, K. Kieburtz, P. Litman, H. Friedman, S. Oren (Sarasota, USA)

    Objective: Evaluate the efficacy and safety of P2B001 compared with its components and with Extended-Release pramipexole (ER-PPX, calibration arm) in untreated PD. Background: P2B001 is…
  • 2022 International Congress

    Postural Instability in Parkinson’s Disease: Phenotypic data from The Cincinnati Cohort Biomarker Program

    K. Duque, J. Abanto, R. Bode, N. Gregor, F. Pariona, J. Hernandez, A. Espay, L. Marsili (Cincinnati, USA)

    Objective: To estimate the onset of postural instability in a cohort of Parkinson's disease (PD) patients. Background: The Cincinnati Cohort Biomarker Program (CCBP), launched in…
  • 2022 International Congress

    Caregiving patients with Parkinson disease treated with deep brain stimulation: a systematic review and meta-synthesis of qualitative research

    V. Fioravanti, F. Cavallieri, F. Sireci, M. Parmeggiani, C. Pedroni, F. Mardones, M. Bassi, E. Moro, L. Ghirotto, F. Valzania (Reggio Emilia, Italy)

    Objective: To explore the experiences and unmet needs of Parkinson disease patients (PDPs) caregivers after subthalamic nucleus deep brain stimulation (STN-DBS) by performing a systematic…
  • 2022 International Congress

    Nutritional Status of Patients with Parkinson’s Disease: Report from Indonesian Tertiary Referral Hospital

    SS. Musthafa, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: This study aimed to describe and determine the prevalence of nutritional status in outpatient Parkinson’s Disease (PD) patients. Background: Parkinson’s disease is the most…
  • 2022 International Congress

    Non-Invasive Brain Stimulation for the Treatment of Psychiatric Symptoms in Parkinson’s Disease: A Systematic Review and Meta-analysis

    Y. Qu (Wuhan, China)

    Objective: This meta-analysis aims to assess the effect of NIBS technique for psychiatric symptoms in patients with PD. Background: Non-invasive brain stimulations (NIBS), especially repetitive…
  • 2022 International Congress

    Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up

    T. Fedorova, K. Knudsen, K. Andersen, J. Horsager, C. Skjærbæk, M. Otto, K. Svendsen, P. Borghammer (Aarhus N, Denmark)

    Objective: To image progression of intestinal dysfunction, cardiac sympathetic denervation, and dopaminergic nigrostriatal damage in patients with isolated REM sleep behaviour disorder (iRBD). Background: A…
  • 2022 International Congress

    [18F]FDG PET in hyperkinetic movement disorders: a systematic review

    E. Timmers, M. Klamer, R. Marapin, A. Lammertsma, B. de Jong, R. Dierckx, M. Tijssen (Groningen, Netherlands)

    Objective: To give a comprehensive literature overview of alterations in regional cerebral glucose metabolism, measured using [18F]FDG PET, in hyperkinetic movement disorders. In addition, correlations…
  • 2022 International Congress

    Muscarinic M2 cholinergic receptors in cervical dystonia

    P. Kassavetis, M. Hosseini, K. Mente, R. Waugh, E. Shamim, W. Dieckmann, P. Herscovitch, M. Hallett, S. Horovitz (Salt Lake City, USA)

    Objective: To characterize the M2 muscarinic acetylcholine receptor binding in patients with cervical dystonia, measured with non-invasive high-resolution PET, using [18F]FP-TZTP ligand. Background: While antimuscarinic…
  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley